Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease

被引:20
|
作者
Saroja, Sivaprakasam R. [1 ,2 ,3 ]
Sharma, Abhijeet [1 ,2 ,3 ]
Hof, Patrick R. [2 ,3 ,4 ]
Pereira, Ana C. [1 ,2 ,3 ,4 ]
机构
[1] Icahn Sch Med, Dept Neurol, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Nash Family Dept Neurosci, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA
关键词
Alzheimer's disease; cognitive impairment; extracellular vesicles and Serpina3n; neurodegeneration; synaptic loss; tau pathology; PAIRED HELICAL FILAMENTS; AXONAL-TRANSPORT; NEUROFIBRILLARY TANGLES; EXTRACELLULAR VESICLES; SPATIAL MEMORY; PROTEIN; ACTIVATION; PATHOLOGY; DEFICITS; KINESIN;
D O I
10.1002/alz.12518
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pathological tau proteins in patients with Alzheimer's disease (AD) mainly accumulate in the form of neurofibrillary tangles (NFTs) and neuritic plaques (NPs). However, the molecular properties of tau species present in NFTs and NPs are not known. We tested the hypothesis that tau species within NFT-predominant tissue (NFT_AD) are distinct and more toxic than those in NP-predominant tissue (NP_AD). We analyzed the tau species from post mortem prefrontal cortical brains of NFT_AD and NP_AD. Compared to NP_AD, NFT_AD displayed highly phosphorylated tau oligomers, possessed tau oligomers in extracellular vesicles, and the 3-repeat (3R) and 4-repeat (4R) isoforms were differentially expressed between the groups. Comparison of tau proteins isolated from NFT- versus NP-AD subjects demonstrated higher tau seeding activity in NFT subjects and a greater degree of inducing synaptic loss in cultured neurons. We propose that tau species from NFT-predominant tissues possess greater levels of degenerative properties, thereby causing synaptic loss and cognitive decline.
引用
收藏
页码:1602 / 1615
页数:14
相关论文
共 50 条
  • [1] Association of Presynaptic Loss with Alzheimer's Disease and Cognitive Decline
    Lan, Guoyu
    Cai, Yue
    Li, Anqi
    Liu, Zhen
    Ma, Shaohua
    Guo, Tengfei
    ANNALS OF NEUROLOGY, 2022, 92 (06) : 1001 - 1015
  • [2] Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
    Pereira, Joana B.
    Janelidze, Shorena
    Ossenkoppele, Rik
    Kvartsberg, Hlin
    Brinkmalm, Ann
    Mattsson-Carlgren, Niklas
    Stomrud, Erik
    Smith, Ruben
    Zetterberg, Henrik
    Blennow, Kaj
    Hansson, Oskar
    BRAIN, 2021, 144 : 310 - 324
  • [3] Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer's disease
    Wang, Jie
    Huang, Qi
    Chen, Xing
    You, Zhiwen
    He, Kun
    Guo, Qihao
    Huang, Yiyun
    Yang, Yang
    Lin, Zengping
    Guo, Tengfei
    Zhao, Jun
    Guan, Yihui
    Li, Binyin
    Xie, Fang
    MOLECULAR PSYCHIATRY, 2024, 29 (09) : 2799 - 2809
  • [4] L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer’s Disease
    Baruh Polis
    Kolluru D. Srikanth
    Evan Elliott
    Hava Gil-Henn
    Abraham O. Samson
    Neurotherapeutics, 2018, 15 : 1036 - 1054
  • [5] L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer's Disease
    Polis, Baruh
    Srikanth, Kolluru D.
    Elliott, Evan
    Gil-Henn, Hava
    Samson, Abraham O.
    NEUROTHERAPEUTICS, 2018, 15 (04) : 1036 - 1054
  • [6] Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction
    Reddy, PH
    Mani, G
    Park, BS
    Jacques, J
    Murdoch, G
    Whetsell, W
    Kaye, J
    Manczak, M
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 7 (02) : 103 - 117
  • [7] Microglial activation and tau burden predict cognitive decline in Alzheimer's disease
    Malpetti, Maura
    Kievit, Rogier A.
    Passamonti, Luca
    Jones, P. Simon
    Tsvetanov, Kamen A.
    Rittman, Timothy
    Mak, Elijah
    Nicastro, Nicolas
    Bevan-Jones, W. Richard
    Su, Li
    Hong, Young T.
    Fryer, Tim D.
    Aigbirhio, Franklin, I
    O'Brien, John T.
    Rowe, James B.
    BRAIN, 2020, 143 : 1588 - 1602
  • [8] Alzheimer's disease:: Aβ, tau and synaptic dysfunction
    LaFerla, FM
    Oddo, S
    TRENDS IN MOLECULAR MEDICINE, 2005, 11 (04) : 170 - 176
  • [9] Association of Rapidly Elevated Plasma Tau Protein With Cognitive Decline in Patients With Amnestic Mild Cognitive Impairment and Alzheimer's Disease
    Chu, Che-Sheng
    Lin, Yu-Kai
    Tsai, Chia-Lin
    Sung, Yueh-Feng
    Lin, Guan-Yu
    Ko, Chien-An
    Liu, Yi
    Liang, Chih-Sung
    Yang, Fu-Chi
    PSYCHIATRY INVESTIGATION, 2025, 22 (02) : 130 - 139
  • [10] Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
    DeFelipe, Javier
    FRONTIERS IN NEUROANATOMY, 2016, 10